免疫治療科普英文_第1頁
免疫治療科普英文_第2頁
免疫治療科普英文_第3頁
免疫治療科普英文_第4頁
免疫治療科普英文_第5頁
已閱讀5頁,還剩23頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

演講人:日期:免疫治療科普英文IntroductiontoImmunotherapyHowDoesImmunotherapyWork?BenefitsandRisksofImmunityLatestResearchandDevelopmentsinImmunotherapyAccessingandAffordabilityTreatments目錄01IntroductiontoImmunotherapyImmunotherapyisatypeofcancertreatmentthatusesthebody'sownimmunesystemtofitcancercellsItworksbystimulatingorrestoringtheimmunesystem'sabilitytorecognizeandattachcancercellsImmunotherapycanbeusedaloneorincombinationwithothercancertreatments,suchassurgery,chemotherapy,orradiationtherapyWhatisImmunotherapy?Earlyformsofhomologydatebacktothelate19thcenturywhendoctorsbeginusingbacteriaortoxinstostimulatetheimmunesystemInthe1970s,researchersdiscoveredthattheimmunesystemcouldbetrainedtorecognizeandattachcancercellsOverthepastdecade,therehasbeenasurgeinthedevelopmentofnewessentialdrugsandtechnologies,leadingtoimprovedoutcomesformanypatientsHistoryandDevelopmentofImmunotherapyThisisthebody'sfirstlineofdefenseagainstforeigninvaders,includingbacteria,viruses,andcancercellsItincludesphysicalbarriers(suchasskinandmucousmembranes)andchemicalbarriers(suchasacidsandenzymes)InnateImmunityThisisthebody'smorespecificandlonglastimmuneresponseItinvolvestheproductionofantibioticsandtheactivationofT-cellstotargetanddestroyspecificinvaders,includingcancercellsAdaptiveImmunityTypesofImmunities

WhoCanBenefitfromImmunotherapy?Patientswithcancertypesofcancer,suchasmalaria,lungcancer,andbladdercancer,maybenefitfromimmunotherapyImmunotherapymaybesignificantlyeffectiveforpatientswhohaverecurrentorspreaddespiteothertreatmentsSomepatientsmaybeeligibleforimmunotherapyaspartofaclinicaltrialtotestnewbugsorcombinationsoftreatments02HowDoesImmunotherapyWork?Immunotherapystimulatesthebody'sownimmunesystemtorecognizeandattachcancercellsImmunecheckpointinhibitorsarebugsthatblockcancerproteinsoncancercells,allowingtheimmunesystemtoidentifyanddestroythemCytokinesareproteinsthatstimulatetheimmunesystemandcanbeusedtoenhancethebody'sresponsetocancerSimulatingtheImmuneSystemMonoclonalantibioticsarelaboratoryproducedmoldsthatattachtospecifictargetsoncancercellsSpecificantibioticscansimilarlyattachtotwodifferentantibiotics,eitheronthesameordifferentcancercells,enhancingtheimmuneresponseAntibodydrugconnections(ADCs)areantibioticslinkedtocancerkillingdrugs,deliveringthemedicinedirectlytothetuitionsiteTargetingCancerCellswithAntibodies01ACTinvolvescollectingandusingpatients'ownimmunecells,whichhavebeenmodifiedtoattackcancercells02T-celltherapy,atypeofACT,involvingisolationandmultiplyingapatient'sT-cellsinthelaboratorybeforereintroducingthemintothebodytofitcancer03CART-celltherapyisaspecializedtypeofT-celltherapywheretheT-cellsaregeneticallymodifiedtoproducechiralantigenreceptors(CARs)thattargetspecificantigensoncancercellsAdaptiveCellTransfer(ACT)TherapeuticcancervaccinesstimulatetheimmunesystemtoattackspecificcancercellsPersonalizedvaccinesarecreatedusingapatient'sowntuberantstoelicitamoretargetedimmuneresponse單擊此處添加正文,文字是您思想的為了最終呈現(xiàn)發(fā)布的。單擊此處添加正文文字是您思。文字是您思。單擊此處添加正文文字是您思。文字是您思。4行*21字Dendriticcellvaccinesuseapatient'sowndendriticcells,whichareloadedwithcancerantigensandthenreintroducedintothebodytostimulateanimmuneresponseVaccinesforCancerTreatment03BenefitsandRisksofImmunityEnhancedimmuneresponseImmunotherapycanstimulatethebody'sownimmunesystemtorecognizeandattachcancercellsmoreeffectivelyTargetedtreatmentUnlikechemotherapy,whichaffectsbothhealthandcancercells,negligibletargetsspecificproteinsormarkersoncancercells,leavinghealthcellslargeunharmedDurableresponseInsomecases,negligiblecanprovidelongtermremittanceorevenacure,astheimmunesystemcontinuestofitthecancerevenaftertreatmenthasendedPotentialBenefitsofImmunoherapyInflammationandautoimmunereactionsImmunotherapycanstimulatesomeemotionswithanoveractiveimmuneresponse,leadingtoinflationorautoimmunediseasesAllergicreactionsSomeimmunotherapydrugscancauseAllergicreactions,rangingfrommilltosevereInfectionriskBecausetheimmunesystem,itcanincreasetheriskofinfectionCommonSideEffectsandRisksMedicalmanagementPrescriptiontreatmentscanbeusedtotreatinflammation,pain,andothersideeffectsLifestylemodificationsChangesindie,exercise,andsleephabitscanhelpreducetheseverityofsideeffectsandimproveoverallhealthClosemonitoringRegularcheckupsandbloodtestscanhelpidentifyandmanagesideeffectsearlyManagingSideEffectswithSupportingCareContinuousmonitoringEvenaftertreatmenthasended,regularcheckupsandmonitoringareimportanttoensurethatthecancerhasnotbeenreturnedPotentialforlongtermremovalInsomecases,negligiblecanprovidelongtermremovalorevenacureOngoingresearchanddevelopmentImmunotherapyisarapidlydevelopingfield,andnewtreatmentsandcombinationsoftreatmentsarecontinuouslybeingstudiedandtestedLongTermOutlookafterImmunotherapy04LatestResearchandDevelopmentsinImmunotherapyCombinationofImmunoherapyandChemotherapyCombiningimmunoherapybugswithchemotherapyhasshownpromiseresultsinshrinkingtubersandprolongingsurvivalinsomecancerpatientsImmunotherapyandRadiationTherapyRadiationtherapycanenhancetheeffectsofimmunitybyreleasingtumorantigensandstimulatingtheimmunesystemtoattackcancercellsTargetedTherapyandImmunotherapyTargetedtherapydrugsthatspecificallytargetcancercellsincancercellscanbecombinedwithimmunotherapytoachievebettertreatmentoutcomesCombinationTherapywithOtherTreatmentsGeneticTestingforPersonalizedTreatmentGenetictestingofstudentscanhelpidentifyspecificmutationsthatcanbetargetedbyimmunotherapydrugs,enablingpersonalizedtreatmentplansBiomerkerDrivenClinicalTrialsClinicaltrialsareincreasinglyfocusingonbiomarkerdrivenpatientselectiontoensurethattherightpatientsreceivethemosteffectiveimmunotherapytreatmentsDevelopmentofPersonalizedVacanciesPersonalizedVacanciesarebeingdevelopedthatstimulatestheimmunesystemtoattackspecifictuberantsuniquetoeachpatient'scancerPersonalizedMedicineandPrecisionImmunotherapy010203ImmuneCheckpointInhibitorsImmuneCheckpointInhibitorsareatypeofimmunitydrugthatblockscontainproteinsonimmunecells,allowingthemtoattackcancercellsmoreeffectivelyT-CellEngagingTherapyT-cellengagingtherapiesinvolvetheuseofengineeredT-cellsorantibioticsthatdirectT-cellstoattackcancercellsTumorInfiltratingLymphocytes(TILs)TILsareatypeofimmunecellfoundwithintutorsthatcanbeisolated,expanded,andreinfusedintopatientstoattacktheircancerNewTargetsforCancerImmunotherapyDevelopmentofMoreEffectandLessToxicImmunoherapyDrugsOngoingresearchisfocusedondevelopingnewimmunoherapydrugsthataremoreeffectiveandhavefeltsideeffectsthatarecurrenttreatmentsCombinationofImmunotherapywithOtherEmergingTechnologiesImmunotherapyisbeingcombinedwithotheremergingtechnologies,suchasgeneeditingandcelltherapy,tocreatemorepowerfulandtargetedtreatmentsforcancerUnderstandingtheRoleoftheMicrobiomeinImmunotherapyResponseResearchisalsoexploringtheroleofthemicrobiome(thecollectionofmicroorganismsinthebody)indeterminingapatient'sresponsetoimmunotherapytreatmentsFutureDirectionsinResearch05AccessingandAffordabilityTreatmentsSearchingOnlineDatabasesUtilizeonlineclinicaltrialdatabasesortreatmentcenterdirectoriestofindimmunodeficiencyoptionsConsultingwithHealthcareProvidersDiscussionswithyourhealthcareprovideraboutpotentialclinicaltrialsortreatmentcentersAttendingMedicalConferencesMedicalconferencesoftenprovideinformationaboutthelatestessentialresearchandtreatmentoptionsFindingClinicalTrialsorTreatmentCentersCostVariesbyTreatmentType01Thecostofnegligiblecanvarywidelydependingonthetypeoftreatment,suchasmonoclonalantibiotics,cancervaccines,orcellbasedtherapiesInsuranceCoverage02CheckwithyourinsuranceprovidertounderstandwhatessentialtreatmentsarecoveredandwhatoutofpocketcostsmaybeinvolvedCostBenefitAnalysis03ConsiderthepotentialbenefitsofimmunotherapyinrelationtoitscostUnderstandingtheCostofImmunotherapyPharmaceuticalCompanyProgramsManypharmaceutica

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論